King of Prussia, PA, United States of America

Michael P Demartino


 

 

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Michael P. Demartino: Innovator in Pharmaceutical Compounds

Introduction

Michael P. Demartino is a notable inventor based in King of Prussia, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases involved in various diseases. With a total of three patents to his name, his work has the potential to impact therapeutic approaches for numerous gastrointestinal and cancer-related disorders.

Latest Patents

One of Michael P. Demartino's latest patents focuses on novel compounds that act as inhibitors of the Rearranged during Transfection (RET) kinase. This invention encompasses pharmaceutical compositions containing these compounds, as well as processes for their preparation. The therapeutic applications of these compounds are extensive, targeting conditions such as irritable bowel syndrome (IBS), functional gastrointestinal disorders, and various types of cancer, including non-small cell lung cancer and colorectal cancer. The potential benefits of these compounds extend to the normalization of gastrointestinal sensitivity, motility, and secretion, making them a promising avenue for treatment.

Career Highlights

Michael P. Demartino is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong focus on developing therapeutic solutions that address complex medical conditions. His expertise in the field has positioned him as a valuable contributor to advancements in drug development.

Collaborations

Throughout his career, Michael has collaborated with talented individuals such as Mui Cheung and Hilary Schenck Eidam. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of impactful pharmaceutical solutions.

Conclusion

Michael P. Demartino's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving therapeutic options for patients. His work in developing RET inhibitors showcases the potential for significant advancements in treating gastrointestinal and cancer-related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…